ArticleScientific reports2025
A scoping review and modelling of predictors of an abnormal Thompson score in term neonates in low-resource settings.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global, regional, and national burden and trends of neonatal encephalopathy.Pediatric research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Clinical risk scores, such as Thompson score, are useful alternatives to identify neonatal encephalopathy in low-resource settings where adequate training and equipment are often unavailable. An understanding of the clinical predictors of abnormally high Thompson score values would be beneficial to identify term neonates with suspected neonatal encephalopathy. A scoping review was conducted to identify a set of a priori neonatal and maternal variables associated with neonatal encephalopathy. Next, a prospective study of all term neonates admitted to Sally Mugabe Central Hospital in Zimbabwe between October 2020 and December 2022 was conducted to develop a predictive statistical model of abnormal (> 10) Thompson score. In total 45 articles were identified from searching Medline, Scopus and Web of Science and 10 articles were selected. Five studies were conducted in countries in Asia and five in Africa. Of 6,054 neonates who met the inclusion criteria, 4.06% (n = 246) had an abnormal Thompson score at admission with a case fatality rate of 589 per 1000 admissions. Among these neonates, 90.65% (n = 223) had a low Apgar score (p < 0.001). 40 candidate predictors were identified, of which 20 predictors were selected as the most important. Six risk factors were predictive of neonates at risk of abnormal Thompson score, including low neonatal heart rate (aOR = 0.97), temperature lower than 36.5 °C (aOR = 2.24), head swelling (aOR = 2.19), other maternal risk factors of sepsis excluding offensive liquor and premature rupture of membranes (aOR = 1.97), meconium-stained umbilicus (aOR = 1.79), and not crying at birth (aOR = 2.58). These identified risk factors should be prioritised before conducting a Thompson score assessment in resource-poor settings, and local clinical guidelines should incorporate these into the clinical management of at-risk neonates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.